Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Companion Study of Quality in Life in Patients With Advanced Non-Small Cell Lung Cancer Treated With Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin on Protocol JMTO-LC00-03

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Natural history/Epidemiology	Closed	18 and over	Other	NHOK-BRI-LC03-01 NCT00242983

Trial Description

Purpose:

Studying quality-of-life in patients undergoing cancer treatment may help identify the intermediate and long-term effects of treatment on patients with cancer.

This clinical trial is studying quality of life in patients who are receiving either vinorelbine, gemcitabine, and docetaxel or paclitaxel and carboplatin for advanced non-small cell lung cancer.

Eligibility:

Eligibility criteria include the following:

• At least 18 years old
• Enrolled on clinical trial JMTO-LC00-03
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will complete questionnaires on quality of life before beginning treatment, at 9 and 18 weeks during treatment, and after finishing treatment.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

National Hospital Organization Kinki-chuo Chest Medical Center

Masaaki Kawahara, MD, Protocol chair		Ph: 81-72-252-3021 Email: kawaharam@kch.hosp.go.jp

Related Information

PDQ® clinical trial JMTO-LC00-03

Registry Information
Official Title		Assessment of Quality of Life (QOL) in Patients Registered with "Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients with Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)"
Trial Start Date		2004-04-08
Registered in ClinicalTrials.gov		NCT00242983
Date Submitted to PDQ		2005-09-29
Information Last Verified		2005-12-14

Back to Top